Alpelisib (Standard) is the analytical standard of Alpelisib. This product is intended for research and analytical applications. Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kalpha inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110alpha/p110gamma/p110delta/p110beta with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity[1][2][3].
Molekulargewicht:
441.47
Reinheit:
99.86
CAS Nummer:
[1217486-61-7]
Formel:
C19H22F3N5O2S
Target-Kategorie:
PI3K,Reference Standards
Anwendungsbeschreibung:
MCE Product type: Reference Standards
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten